Immunotherapy startup Celuarity announced the FDA has cleared its application for an investigational new stem cell therapy against COVID-19.
FDA Greenlights Clinical Trial For COVID-19 Coronavirus Treatment That ‘Flattens The Curve’ In Patients
Immunotherapy startup Celuarity announced the FDA has cleared its application for an investigational new stem cell therapy against COVID-19.